Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker ESLA
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Oct 29, 2026 | ESLA Estrella Immunopharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 29, 2026 | ESLA Estrella Immunopharma, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 8, 2026 | ESLA Estrella Immunopharma, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Aug 21, 2026 | ESLA Estrella Immunopharma, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Jun 30, 2026 | ESLA Estrella Immunopharma, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jan 13, 2026 | ESLA Estrella Immunopharma, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Jan 6, 2026 | ESLA Estrella Immunopharma, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 6, 2026 | ESLA Estrella Immunopharma, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jan 6, 2026 | ESLA Estrella Immunopharma, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 4, 2025 | ESLA Estrella Immunopharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 6, 2025 | ESLA Estrella Immunopharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 29, 2025 | ESLA Estrella Immunopharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 26, 2025 | ESLA Estrella Immunopharma, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 7, 2025 | ESLA Estrella Immunopharma, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Jun 5, 2025 | ESLA Estrella Immunopharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 3, 2025 | ESLA Estrella Immunopharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 3, 2025 | ESLA Estrella Immunopharma, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jun 3, 2025 | ESLA Estrella Immunopharma, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 29, 2025 | ESLA Estrella Immunopharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 2, 2025 | ESLA Estrella Immunopharma, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Feb 21, 2025 | ESLA Estrella Immunopharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 20, 2025 | ESLA Estrella Immunopharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 16, 2024 | ESLA Estrella Immunopharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 6, 2024 | ESLA Estrella Immunopharma, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 26, 2024 | ESLA Estrella Immunopharma, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Nov 25, 2024 | ESLA Estrella Immunopharma, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Nov 7, 2024 | ESLA Estrella Immunopharma, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K/A | 8-K ↗ |
| Nov 7, 2024 | ESLA Estrella Immunopharma, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K/A | 8-K ↗ |
| Nov 7, 2024 | ESLA Estrella Immunopharma, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
29 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 16, 2026, 6:44 AM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances